Enliven Therapeutics files initial beneficial ownership statement for director Kristine M. Ball
ELVN•Director Kristine M. Ball filed an initial beneficial ownership statement dated Oct. 16, 2026.
1. Ownership filing
Enliven Therapeutics director Kristine M. Ball filed an initial statement of beneficial ownership dated Oct. 16, 2026.
